Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Aase

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Developments in Biological Standardization|April 29, 1998
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccineE Rosenqvist, E A Høiby, G Bjune, et al.
Mayo Clinic Proceedings|February 24, 2001
Attitudes of Olmsted County, Minnesota, residents about tobacco smoke in restaurants and barsT E Kottke, L A Aase, C L Brandel, et al.
Vaccine|October 15, 2013
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccinesG Tunheim, M Arnemo, L M Næss, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
American Journal of Preventive Medicine|February 7, 2006
CardioVision 2020: program acceptance and progress after 4 yearsThomas E Kottke, Randal J Thomas, Francisco Lopez-Jimenez, et al.
Mayo Clinic Proceedings|February 13, 2002
Self-reported weight, weight goals, and weight control strategies of a midwestern populationThomas E Kottke, Matthew M Clark, Lee A Aase, et al.
Clinical and Vaccine Immunology : CVI|May 29, 2009
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adultsH Findlow, B D Plikaytis, A Aase, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Developments in Biological Standardization|April 29, 1998
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccineE Rosenqvist, E A Høiby, G Bjune, et al.
Mayo Clinic Proceedings|February 24, 2001
Attitudes of Olmsted County, Minnesota, residents about tobacco smoke in restaurants and barsT E Kottke, L A Aase, C L Brandel, et al.
Vaccine|October 15, 2013
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccinesG Tunheim, M Arnemo, L M Næss, et al.
Developments in Biological Standardization|April 29, 1998
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvantB Haneberg, R Dalseg, F Oftung, et al.
American Journal of Preventive Medicine|February 7, 2006
CardioVision 2020: program acceptance and progress after 4 yearsThomas E Kottke, Randal J Thomas, Francisco Lopez-Jimenez, et al.
Mayo Clinic Proceedings|February 13, 2002
Self-reported weight, weight goals, and weight control strategies of a midwestern populationThomas E Kottke, Matthew M Clark, Lee A Aase, et al.
Clinical and Vaccine Immunology : CVI|May 29, 2009
Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adultsH Findlow, B D Plikaytis, A Aase, et al.
Pageof 8